Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism

Thrombosis Journal

Volumn 6, Issue , 2008, Pages

  Huerta, Consuelo ^a   Johansson, Saga ^b,c   Wallander, Mari Ann ^d   Rodríguez, Luis ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MORTALITY; NEOPLASM; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; UNITED KINGDOM; VENOUS THROMBOEMBOLISM;

EID: 51349158249     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-6-10     Document Type: Article

References (30)

1. Prandoni P Ghirarduzzi A Prins MH Pengo V Davidson BL Sorensen H Pesavento R Iotti M Casiglia E Iliceto S Pagnan A Lensing AW Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis J Thromb Haemost 2006, 4:1891-1896. 10.1111/j.1538-7836.2006.02058.x 16961597
2. Becattini C Agnelli G Prandoni P Silingardi M Salvi R Taliani MR Poggio R Imberti D Ageno W Pogliani E Porro F Casazza F A prospective study on cardiovascular events after acute pulmonary embolism Eur Heart J 2005, 26:77-83. 10.1093/eurheartj/ehi018 15615803
3. Schulman S Lindmarker P Holmstrom M Larfars G Carlsson A Nicol P Svensson E Ljungberg B Viering S Nordlander S Leijd B Jahed K Hjorth M Linder O Beckman M Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months J Thromb Haemost 2006, 4:734-742. 10.1111/j.1538-7836.2006.01795.x 16634738
4. Jick H Jick SS Derby LE Validation of information recorded on general practitioner based computerised data resource in the United Kingdom BMJ 1991, 302:766-768. 1669537 2021768
5. Jick SS Kaye JA Vasilakis-Scaramozza C Garcia Rodriguez LA Ruigomez A Meier CR Schlienger RG Black C Jick H Validity of the general practice research database Pharmacotherapy 2003, 23:686-689. 10.1592/ phco.23.5.686.32205 12741446
6. Lawrenson R Todd JC Leydon GM Williams TJ Farmer RD Validation of the diagnosis of venous thromboembolism in general practice database studies Br J Clin Pharmacol 2000, 49:591-596. 2015047 10848723 10.1046/ j.1365-2125.2000.00199.x
7. Jick H Jick SS Gurewich V Myers MW Vasilakis C Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components Lancet 1995, 346:1589-1593. 10.1016/S0140-6736(95)91928-7 7500750
8. Vasilakis C Jick H del Mar Melero-Montes M Risk of idiopathic venous thromboembolism in users of progestagens alone Lancet 1999, 354:1610-1611. 10.1016/S0140-6736(99)04394-9 10560680
9. Perez Gutthann S Garcia Rodriguez LA Castellsague J Duque Oliart A Hormone replacement therapy and risk of venous thromboembolism: population based case-control study Bmj 1997, 314:796-800. 2126205 9081000
10. Meier CR Jick H Tamoxifen and risk of idiopathic venous thromboembolism Br J Clin Pharmacol 1998, 45:608-612. 1873655 9663819 10.1046/ j.1365-2125.1998.00733.x
11. Huerta C Wallander MA Johansson S Garcia Rodriguez LA Natural history of venous thromboembolism diagnosed in UK primary care Arch Int Med
12. White RH The epidemiology of venous thromboembolism Circulation 2003, 107:I4-8. 10.1161/01.CIR.0000078468.11849.66 12814979
13. Bova C Marchiori A Noto A Rossi V Daniele F Santoro C Ricchio R De Lorenzo R Umbaca R Prandoni P Incidence of arterial cardiovascular events in patients with idiopathic venous thromboembolism. A retrospective cohort study Thromb Haemost 2006, 96:132-136. 16894454
14. Garcia Rodriguez LA Varas-Lorenzo C Maguire A Gonzalez-Perez A Nonsteroidal antiinflammatory drugs and the risk of myocardial infarction in the general population Circulation 2004, 109:3000-3006. 10.1161/01.CIR.0000132491.96623.04 15197149
15. Volmink JA Newton JN Hicks NR Sleight P Fowler GH Neil HA Coronary event and case fatality rates in an English population: Results of the Oxford myocardial infarction incidence study. The Oxford Myocardial Infarction Incidence Study Group Heart 1998 , 80:40-44. 1728738 9764057
16. Tunstall-Pedoe H Kuulasmaa K Amouyel P Arveiler D Rajakangas AM Pajak A Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents Circulation 1994, 90:583-612. 8026046
17. Prandoni P Bilora F Marchiori A Bernardi E Petrobelli F Lensing AW Prins MH Girolami A An association between atherosclerosis and venous thrombosis N Engl J Med 2003, 348:1435-1441. 10.1056/NEJMoa022157 12686699
18. Hong C Zhu F Du D Pilgram TK Sicard GA Bae KT Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism Atherosclerosis 2005, 183:169-174. 10.1016/ j.atherosclerosis.2005.03.047 15939424
19. Sørensen HT Horvath-Puho E Pedersen L Baron JA Prandoni P Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: A 20-year cohort study Lancet 2007, 370:1773-1779. 10.1016/S0140-6736(07)61745-0 18037081
20. Heit JA Silverstein MD Mohr DN Petterson TM O'Fallon WM Melton LJ 3rd Predictors of survival after deep vein thrombosis and pulmonary embolism: A population-based, cohort study Arch Intern Med 1999, 159:445-453. 10.1001/archinte.159.5.445 10074952
21. Ribeiro A Lindmarker P Johnsson H Juhlin-Dannfelt A Jorfeldt L Pulmonary embolism: One-year follow-up with echocardiography doppler and five-year survival analysis Circulation 1999, 99:1325-1330. 10077516
22. Horlander KT Mannino DM Leeper KV Pulmonary embolism mortality in the United States, 1979-1998: An analysis using multiple-cause mortality data Arch Intern Med 2003, 163:1711-1717. 10.1001/archinte.163.14.1711 12885687
23. Prandoni P Lensing AW Cogo A Cuppini S Villalta S Carta M Cattelan AM Polistena P Bernardi E Prins MH The long-term clinical course of acute deep venous thrombosis Ann Intern Med 1996, 125:1-7. 8644983
24. Lee AY Levine MN Venous thromboembolism and cancer: Risks and outcomes Circulation 2003, 107:I17-21. 12814981
25. Reich LM Folsom AR Key NS Boland LL Heckbert SR Rosamond WD Cushman M Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism J Thromb Haemost 2006, 4:1909-1913. 10.1111/ j.1538-7836.2006.02121.x 16836659
26. Goldhaber SZ Grodstein F Stampfer MJ Manson JE Colditz GA Speizer FE Willett WC Hennekens CH A prospective study of risk factors for pulmonary embolism in women JAMA 1997, 277:642-645. 10.1001/ jama.277.8.642 9039882
27. Tsai AW Cushman M Rosamond WD Heckbert SR Polak JF Folsom AR Cardiovascular risk factors and venous thromboembolism incidence: The longitudinal investigation of thromboembolism etiology Arch Intern Med 2002, 162:1182-1189. 10.1001/archinte.162.10.1182 12020191
28. van der Hagen PB Folsom AR Jenny NS Heckbert SR O'Meara ES Reich LM Rosendaal FR Cushman M Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study J Thromb Haemost 2006, 4:1903-1908. 10.1111/j.1538-7836.2006.02096.x 16961598
29. Ageno W Prandoni P Romualdi E Ghirarduzzi A Dentali F Pesavento R Crowther M Venco A The metabolic syndrome and the risk of venous thrombosis: A case-control study J Thromb Haemost 2006, 4:1914-1918. 10.1111/j.1538-7836.2006.02132.x 16848878
30. Jick H Derby LE Gurewich V Vasilakis C The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension Pharmacotherapy 1996, 16:321-326. 8726591